|
Pharmacosmos is considered a world leading authority in treatment of iron deficiency anaemia. The privately owned specialty pharmaceutical company, established in 1965 in Holbaek outside Copenhagen, Denmark, markets its human and veterinary medicines in a large number of markets throughout the world. The company’s brands are MonoFer®, CosmoFer® and Uniferon®. Pharmacosmos maintains an intensive research and development programme targeting iron deficiency therapies and improvement of treatment options. The company is also a world leader in manufacturing of carbohydrate polymers and iron carbohydrate complexes, an expert in dextran fractionation techniques, and supplies clinical grade dextran fractions complying with the major pharmacopoeias (EP, USP and JP). Pharmacosmos employs 125 people in Scandinavia and the UK. ==Company profile== Pharmacosmos was founded in Denmark in 1965 by Henry Marinus Christensen, M.D., Ph.D. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Pharmacosmos」の詳細全文を読む スポンサード リンク
|